Ca2+ dependency of calpain 3 (p94) activation.
Calpain 3, commonly called p94 in the literature, is the abundant skeletal muscle-specific calpain that is genetically linked to limb girdle muscular dystrophy type 2A. Recently, we showed that p94's insertion sequence 1 (IS1) is a propeptide that must be autoproteolytically cleaved to provide access of substrates and inhibitors to the enzyme's active site. Removal of IS1 from the core of p94 by recombinant methods produced a fully active enzyme. Here we have resolved the discrepancies in the literature about the Ca(2+) requirement of p94 using the protease core. Even at substoichiometric levels of Ca(2+), and in competition with EDTA, autoproteolyzed enzyme slowly accumulated. Because the initial autoproteolytic cleavage is an intramolecular reaction, transient binding of two Ca(2+) ions to the core would be sufficient to promote the reaction that is facilitated by having the scissile peptide lying close to the active site cysteine. The second autolytic cleavage was much slower and required higher Ca(2+) levels, consistent with it being an intermolecular reaction. Other metal ions such as Na(+), K(+), and Mg(2+) cannot substitute for Ca(2+) in catalyzing the intramolecular autoproteolysis of the p94 core or in the subsequent hydrolysis of exogenous substrates. These metal ions increase moderately the activity of this enzyme but only at very high concentrations. Thus, the proteolytic activity of the core of p94 and its deletion mutant lacking NS and IS1 was shown to be strictly Ca(2+)-dependent. We propose a two-stage model of activation of the proteolytic core of p94.
Department of Biochemistry and Protein Engineering Network of Centres of Excellence, Queen's University, Kingston, Ontario K7L 3N6, Canada.
Beatriz E
BE
García Díaz
Sherry
S
Gauthier
Peter L
PL
Davies
D001329:Autolysis / Q000378:metabolism; D002118:Calcium / Q000378:metabolism / Q000494:pharmacology*; D002154:Calpain / Q000235:genetics / Q000378:metabolism*; D020134:Catalytic Domain; D003374:Coumarins / Q000378:metabolism; D004251:DNA Transposable Elements / Q000187:drug effects; D004151:Dipeptides / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004492:Edetic Acid / Q000378:metabolism / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D006868:Hydrolysis; D008274:Magnesium / Q000378:metabolism / Q000494:pharmacology; D008954:Models, Biological; D009154:Mutation; D011188:Potassium / Q000378:metabolism / Q000494:pharmacology; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012964:Sodium / Q000378:metabolism / Q000494:pharmacology
D003374:Coumarins; D004251:DNA Transposable Elements; D004151:Dipeptides; D011994:Recombinant Proteins; D004492:Edetic Acid; D012964:Sodium; D002154:Calpain; C078134:calpain p94; D008274:Magnesium; D011188:Potassium; D002118:Calcium